Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the Disease-Reference-Cited by-同舟云学术

Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the Disease

Published:2017-10 Issue:10 Volume:34 Page:2360-2370
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Hodgson Robert,Reason Timothy,Trueman David,Wickstead Rose^ORCID,Kusel Jeanette,Jasilek Adam,Claxton Lindsay,Taylor Matthew,Pulikottil-Jacob Ruth

Funder

Novartis Pharmaceuticals UK Limited

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-017-0620-x.pdf

Reference21 articles.

1. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379(9827):1728–38.

2. Butt T, Tufail A, Rubin G. Health state utility values for age-related macular degeneration: review and advice. Appl Health Econ Health Policy. 2017;15(1):23–32.

3. Mitchell J, Bradley C. Quality of life in age-related macular degeneration: a review of the literature. Health Qual Life Outcomes. 2006;4:97.

4. National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal 2013. 2013. https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781 . Accessed 13 Oct 2016.

5. Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press; 2007.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic Assessment in Resource-Constrained Systems: Individual-Level Simulation Model in Wet Age-Related Macular Degeneration and Diabetic Macular Oedema;Ophthalmology and Therapy;2024-08-06

2. Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost-Effectiveness Analysis;Value in Health;2024-07

3. Cost impact of different treatment regimens of brolucizumab in neovascular age-related macular degeneration: A budget impact analysis;Journal of Managed Care & Specialty Pharmacy;2022-12

4. Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy;BMC Health Services Research;2022-04-29

5. Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study;Health Technology Assessment;2022-01